Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Novel approaches with checkpoint inhibitors in immunotherapy continue to be essential in the treatment of non-small cell lung cancer (NSCLC). However, the low rate of primary response and the development of acquired resistance during the immunotherapy limit their long-term effectiveness. The underly...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292083/
https://www.ncbi.nlm.nih.gov/pubmed/30541627
http://dx.doi.org/10.1186/s40425-018-0468-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292083/
https://www.ncbi.nlm.nih.gov/pubmed/30541627
http://dx.doi.org/10.1186/s40425-018-0468-x

Ejemplares similares